PER 2.86% 7.2¢ percheron therapeutics limited

announcement incoming, page-17

  1. 2,551 Posts.
    lightbulb Created with Sketch. 547
    Hey maybe I am reading this wrong but the trial hasnt started yet. They are putting the pieces together for the application to be lodged eg the staff how its run etc then they lodge the details then they start once approval given so one cannot discount big pharma yet at this stage as we havent started also the big pharma could negotiate anytime so why start now with negotiations if they wanted to join after phase 11 results. Anyway thats my take on it its all my opinion and once again I feel it will be mipomersen approval in the EU as the catalyst so patience all GLTA
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $64.91M
Open High Low Value Volume
7.4¢ 7.4¢ 7.0¢ $44.32K 616.8K

Buyers (Bids)

No. Vol. Price($)
1 4250 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 49809 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.